NO DETECTABLE RESISTANCE TO BULEVIRTIDE MONOTHERAPY THROUGH 96 WEEKS TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS D

被引：0

作者：

Aleman, Soo ^{[1
]}

Liu, Yang ^{[2
]}

Xu, Simin ^{[2
]}

Chang, Silvia ^{[2
]}

Martin, Ross ^{[2
]}

Aeschbacher, Thomas ^{[2
]}

May, Lindsey ^{[2
]}

Manhas, Savrina ^{[2
]}

Han, Dong ^{[2
]}

Yazdi, Tahmineh ^{[2
]}

Martinez, Clarissa ^{[2
]}

Ho, Pui Yan ^{[2
]}

Richards, Christopher ^{[2
]}

Marceau, Caleb ^{[2
]}

Manuilov, Dmitry ^{[2
]}

Flaherty, John F. ^{[2
]}

Maiorova, Evguenia ^{[2
]}

Mo, Hongmei ^{[2
]}

Wedemeyer, Heiner ^{[3
]}

Lampertico, Pietro ^{[4
]}

机构：

[1] Karolinska Inst, Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden

[2] Gilead Sci Inc, Foster City, CA 94404 USA

[3] Hannover Med Sch, Hannover, Germany

[4] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1237-C

引用

页码：S398 / S399

页数：2

共 50 条

[11] Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis D: results from an interim analysis of a phase 3 randomized study
Wedemeyer, Heiner
Aleman, Soo
Brunetto, Maurizia
Blank, Antje
Andreone, Pietro
Bogomolov, Pavel
Chulanov, Vladimir
Mamonova, Nina
Geyvandova, Natalia
Viacheslav, Morozov
Sagalova, Olga
Stepanova, Tatyana
Manuilov, Dmitry
Mercier, Renee-Claude
An, Qi
Flaherty, John F.
Osinusi, Anu
Lau, Audrey
Wiesch, Julian Schulze Zur
Cornberg, Markus
Zeuzem, Stefan
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2023, 78 : S57 - S58
[12] Bulevirtide for Chronic Hepatitis D
Fu, Hua
Liu, Yang
Liu, Qi
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (13): : 1247 - 1248
[13] Bulevirtide for chronic hepatitis D
Baker, Holly
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (10): : 785 - 785
[14] Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48weeks of bulevirtide monotherapy
Lampertico, Pietro
Aleman, Soo
Bogomolov, Pavel
Stepanova, Tatyana
Cornberg, Markus
Ciesek, Sandra
Berger, Annemarie
Manuilov, Dmitry
Li, Mingyang
Lau, Audrey H.
Da, Ben L.
Chee, Grace M.
Brunetto, Maurizia
Zeuzem, Stefan
Wedemeyer, Heiner
JOURNAL OF HEPATOLOGY, 2024, 80 : S794 - S794
[15] No detectable resistance to tenofovir in patients with Adefovir- and Entecavir-resistant chronic hepatitis B after 240 weeks of treatment with tenofovir disoproxil fumarate monotherapy
Choi, Jonggi
Lim, Young-Suk
Lee, Han Chu
Lee, Yung Sang
Byun, Kwan Soo
Kim, Yoon Jun
Yoo, Byung Chul
Kwon, So Young
Gwak, Geum-Youn
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E461 - E461
[16] NO DETECTED RESISTANCE TO TENOFOVIR ALAFENAMIDE ( TAF) THROUGH 96 WEEKS OF TREATMENT IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B
Rosenthal, Philip
Chang, Mei-Hwei
Bezerra, Jorge A.
Liu, Yang
Han, Dong
Xu, Simin
Marceau, Caleb
Yazdi, Tahmineh
May, Lindsey
Li, Robert
Manhas, Savrina
Ho, Pui Yan
Martinez, Clarissa
Peinovich, Nadine
Chang, Silvia
Martin, Ross
Maiorova, Evguenia
Mo, Hongmei
Abramov, Frida
Flaherty, John F.
Schwarz, Kathleen B.
HEPATOLOGY, 2023, 78 : S531 - S532
[17] CONTINUED TREATMENT OF EARLY NONRESPONDER OR PARTIAL VIROLOGIC RESPONDERS WITH BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) THROUGH WEEK 96 LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES
Lampertico, Pietro
Wedemeyer, Heiner
Brunetto, Maurizia
Bogomolov, Pavel
Stepanova, Tatyana
Ciesek, Sandra
Berger, Annemarie
Manuilov, Dmitry
An, Qi
Lau, Audrey
Da, Ben
Flaherty, John
Mercier, Renee-Claude
Zeuzem, Stefan
Cornberg, Markus
Buti, Maria
Aleman, Soo
GUT, 2023, 72 (SUPPL_3) : A101 - A102
[18] CONTINUED TREATMENT OF EARLY NONRESPONDER OR PARTIAL VIROLOGIC RESPONDERS WITH BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) THROUGH WEEK 96 LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES
Lampertico, Pietro
Wedemeyer, Heiner
Brunetto, Maurizia
Bogomolov, Pavel
Stepanova, Tatyana
Ciesek, Sandra
Berger, Annemarie
Manuilov, Dmitry
An, Qi
Lau, Audrey
Da, Ben
Flaherty, John
Mercier, Renee-Claude
Zeuzem, Stefan
Cornberg, Markus
Buti, Maria
Aleman, Soo
GUT, 2023, 72 : A101 - A102
[19] Off-label Bulevirtide monotherapy for chronic hepatitis D virus infection in patients with decompensated liver disease
Dietz-Fricke, Christopher
Degasperi, Elisabetta
Lampertico, Pietro
Jachs, Mathias
Reiberger, Thomas
Grottenthaler, Julia
Berg, Christoph
Herta, Toni
van Boemmel, Florian
Wiegand, Johannes
Berg, Thomas
Reiter, Florian P.
Geier, Andreas
Sprinzl, Kathrin
Zeuzem, Stefan
Buggisch, Peter
Maasoumy, Benjamin
Cornberg, Markus
Wedemeyer, Heiner
Deterding, Katja
JOURNAL OF HEPATOLOGY, 2023, 78 : S108 - S109
[20] Modeling-based response-guided therapy with bulevirtide monotherapy for chronic hepatitis D to identify patients for finite treatment duration
Duehren, Sarah
Shekhtman, Louis
Cotler, Scott
Aberle, Stephan
Reiberger, Thomas
Ferenci, Peter
Dahari, Harel
JOURNAL OF HEPATOLOGY, 2023, 78 : S1170 - S1171

← 1 2 3 4 5 →